Company Profiles

driven by the PitchBook Platform

Alfama

Description

Developer of small-molecule drugs intended to meet the unmet medical needs. The company's small-molecule drugs cure diseases and it focuses on carbon monoxide releasing molecules, enabling patients to get cure of their infectious and inflammatory diseases.

2005

Founded

M&A

Status

11-50

Employees

M&A

Latest Deal Type

$7.68M

Total Amount Raised

Description

Developer of small-molecule drugs intended to meet the unmet medical needs. The company's small-molecule drugs cure diseases and it focuses on carbon monoxide releasing molecules, enabling patients to get cure of their infectious and inflammatory diseases.

Website:

www.alfama.com

Ownership Status

Acquired/Merged

Financing Status

Formerly VC-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

955 Massachusetts Avenue Suite 581 Cambridge, MA 02139United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Alfama's full profile, request a free trial.

    Alfama Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Alfama Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Alfama Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Nuno Arantes-Oliveira Ph.DPresident & Co-Founder
    Nuno Arantes-Oliveira Ph.D President & Co-Founder
    Request full access to PitchBook